Literature DB >> 21307660

Wild-type and mutant p53 proteins interact with mitochondrial caspase-3.

Amanda K Frank1, E Christine Pietsch, Patrick Dumont, Joy Tao, Maureen E Murphy.   

Abstract

Caspases play a key role in the apoptotic pathway by virtue of their ability to cleave key protein substrates within the dying cell. Caspases are produced as inactive zymogens, and need to become proteolytically processed in order to become active. A key executioner caspase, caspase-3, has previously been found to exist in both the cytosol and the mitochondria. At the mitochondria, caspase-3 is associated with both the inner and outer mitochondrial membranes, where it interacts with heat shock proteins Hsp60 and Hsp10. Like caspase-3, a small portion of the p53 tumor suppressor protein is localized to mitochondria, particularly after genotoxic stress. p53 interacts with various members of the Bcl2 family at the mitochondria, and this interaction is key to its ability to induce apoptosis. In this study, we sought to determine the identity of other mitochondrial p53-interacting proteins. Using immunoprecipitation from purified mitochondria followed by mass spectrometry we identified caspase-3 as a mitochondrial p53-interacting protein. Interestingly, we find that tumor-derived mutant forms of p53 retain the ability to interact with mitochondrial caspase-3. Further, we find evidence that these mutant forms of p53 may interfere with the ability of procaspase-3 to become proteolytically activated by caspase-9. The combined data suggest that tumor-derived mutants of p53 may be selected for in tumor cells due to their ability to bind and inhibit the activation of caspase-3.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307660      PMCID: PMC3100564          DOI: 10.4161/cbt.11.8.14906

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  20 in total

Review 1.  Caspase structure, proteolytic substrates, and function during apoptotic cell death.

Authors:  D W Nicholson
Journal:  Cell Death Differ       Date:  1999-11       Impact factor: 15.828

2.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

3.  Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.

Authors:  Jerry E Chipuk; Tomomi Kuwana; Lisa Bouchier-Hayes; Nathalie M Droin; Donald D Newmeyer; Martin Schuler; Douglas R Green
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

Review 4.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

5.  A common polymorphism acts as an intragenic modifier of mutant p53 behaviour.

Authors:  M C Marin; C A Jost; L A Brooks; M S Irwin; J O'Nions; J A Tidy; N James; J M McGregor; C A Harwood; I G Yulug; K H Vousden; M J Allday; B Gusterson; S Ikawa; P W Hinds; T Crook; W G Kaelin
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

6.  Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex.

Authors:  J I-Ju Leu; Patrick Dumont; Michael Hafey; Maureen E Murphy; Donna L George
Journal:  Nat Cell Biol       Date:  2004-04-11       Impact factor: 28.824

Review 7.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

Review 8.  A comparison of the biological activities of wild-type and mutant p53.

Authors:  G P Zambetti; A J Levine
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

9.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

10.  The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling.

Authors:  M Mancini; D W Nicholson; S Roy; N A Thornberry; E P Peterson; L A Casciola-Rosen; A Rosen
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

View more
  20 in total

Review 1.  Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication.

Authors:  Nadi T Wickramasekera; Gokul M Das
Journal:  Mitochondrion       Date:  2013-10-29       Impact factor: 4.160

2.  Cancer Cells Employ Nuclear Caspase-8 to Overcome the p53-Dependent G2/M Checkpoint through Cleavage of USP28.

Authors:  Ines Müller; Elwira Strozyk; Sebastian Schindler; Stefan Beissert; Htoo Zarni Oo; Thomas Sauter; Philippe Lucarelli; Sebastian Raeth; Angelika Hausser; Nader Al Nakouzi; Ladan Fazli; Martin E Gleave; He Liu; Hans-Uwe Simon; Henning Walczak; Douglas R Green; Jiri Bartek; Mads Daugaard; Dagmar Kulms
Journal:  Mol Cell       Date:  2020-01-22       Impact factor: 17.970

3.  Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies.

Authors:  Anneleen Steels; Adriaan Verhelle; Olivier Zwaenepoel; Jan Gettemans
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

Review 4.  Mitochondrial determinants of cancer health disparities.

Authors:  Aaheli Roy Choudhury; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-06       Impact factor: 15.707

5.  Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9.

Authors:  Jacqueline L Y Chee; Suzan Saidin; David P Lane; Sai Mun Leong; Jacqueline E Noll; Paul M Neilsen; Yi Ting Phua; Hani Gabra; Tit Meng Lim
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

6.  Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20.

Authors:  Cédric Castrogiovanni; Marie Vandaudenard; Béranger Waterschoot; Olivier De Backer; Patrick Dumont
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

7.  Study on the apoptosis mechanism induced by T-2 toxin.

Authors:  Zhenhong Zhuang; Daibin Yang; Yaling Huang; Shihua Wang
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

Review 8.  Mitochondrial death functions of p53.

Authors:  N D Marchenko; U M Moll
Journal:  Mol Cell Oncol       Date:  2014-10-31

Review 9.  New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy.

Authors:  Razmik Mirzayans; Bonnie Andrais; April Scott; David Murray
Journal:  J Biomed Biotechnol       Date:  2012-07-15

Review 10.  Mutant p53 in cancer: new functions and therapeutic opportunities.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.